Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Lucira Health, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −6 vs. Q4 2021
- Shares held
- 23.4M
- −1.14M (−4.6%) vs. Q4 2021
- Total value
- $83.7M
- −$127.9M (−60.5%) vs. Q4 2021
- New holders
- 4
- 12 more added
- Sold out
- 10
- 14 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LHDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $321 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $545 |
| Q1 2023 | 6 | $1.46M |
| Q4 2022 | 29 | $1.04M |
| Q3 2022 | 28 | $24.2M |
| Q2 2022 | 38 | $42.2M |
| Q1 2022 | 40 | $83.7M |
| Q4 2021 | 46 | $211.6M |
| Q3 2021 | 36 | $131.9M |
| Q2 2021 | 44 | $107.9M |
| Q1 2021 | 51 | $233.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Lucira Health, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 87 | $0 | 0.00% | −9,495−99.1% | Reduced |
| Captrust Financial Advisors | 319 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,619 | $6.00K | 0.00% | −153−8.6% | Reduced |
| Gemmer Asset Management LLC | 3,000 | $10.0K | 0.00% | +3,000 | New |
| Barclays PLC | 4,016 | $14.0K | 0.00% | +4,016 | New |
| Cutler Group LP | 6,414 | $22.0K | 0.00% | −21,858−77.3% | Reduced |
| Johnson Financial Group, Inc. | 10,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| TrinityPoint Wealth, LLC | 11,000 | $39.0K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 11,000 | $39.0K | 0.00% | +11,000 | New |
| Royal Bank of Canada | 11,660 | $42.0K | 0.00% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 11,898 | $43.0K | 0.00% | +43+0.4% | Added |
| Man Group plc | 12,415 | $44.0K | 0.00% | −254−2.0% | Reduced |
| Morgan Stanley | 13,361 | $48.0K | 0.00% | +803+6.4% | Added |
| Gsa Capital Partners LLP | 13,766 | $49.0K | 0.01% | +13,766 | New |
| Group One Trading, L.P. | 16,859 | $60.0K | 0.00% | +12,756+310.9% | Added |
| Northern Trust Corp | 17,414 | $62.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 17,400 | $62.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 19,648 | $70.0K | 0.00% | −54,917−73.6% | Reduced |
| Resolute Partners Group | 22,800 | $81.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 25,208 | $90.0K | 0.00% | −55,179−68.6% | Reduced |
| Cypress Point Wealth Management, LLC | 27,000 | $96.0K | 0.10% | +12,823+90.4% | Added |
| Tudor Investment Corp Et Al | 31,002 | $111.0K | 0.00% | +15,373+98.4% | Added |
| State Street Corp | 34,890 | $125.0K | 0.00% | −14,610−29.5% | Reduced |
| 683 Capital Management, LLC | 41,629 | $149.0K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 46,736 | $166.0K | 0.01% | −14,196−23.3% | Reduced |
| BlackRock Inc. | 51,468 | $183.0K | 0.00% | +8,131+18.8% | Added |
| Qube Research & Technologies Ltd | 58,790 | $210.0K | 0.00% | −5,939−9.2% | Reduced |
| CastleKnight Management LP | 66,700 | $238.0K | 0.07% | +43,900+192.5% | Added |
| Susquehanna International Group, LLP | 67,392 | $241.0K | 0.00% | −97,120−59.0% | Reduced |
| Ieq Capital, LLC | 74,095 | $265.0K | 0.01% | +890+1.2% | Added |
| Atom Investors LP | 85,921 | $307.0K | 0.14% | +30,442+54.9% | Added |
| Geode Capital Management, LLC | 92,076 | $328.0K | 0.00% | −1,360−1.5% | Reduced |
| Consilio Wealth Advisors, LLC | 97,518 | $348.0K | 0.27% | 00.0% | Unchanged |
| Papp L Roy & Associates | 108,005 | $386.0K | 0.05% | +62,505+137.4% | Added |
| Silverarc Capital Management, LLC | 310,734 | $1.11M | 0.60% | −204,266−39.7% | Reduced |
| Millennium Management LLC | 541,282 | $1.93M | 0.00% | +94,981+21.3% | Added |
| Vanguard Group Inc | 631,767 | $2.26M | 0.00% | +119,929+23.4% | Added |
| Pura Vida Investments, LLC | 687,213 | $2.45M | 0.30% | −478,017−41.0% | Reduced |
| Eclipse Ventures, LLC | 6,223,795 | $22.2M | 5.56% | 00.0% | Unchanged |
| EPIQ Capital Group, LLC | 13,933,620 | $49.7M | 13.60% | −62,630−0.4% | Reduced |
| Data Collective II GP, LLC | 0 | $0 | 0.00% | −296,227−100.0% | Sold out |
| Parian Global Management LP | 0 | $0 | 0.00% | −183,804−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,544−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −13,084−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,915−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −463−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |